RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF RANITIDINE HYDROCHLORIDE AND DOMPERIDONE IN COMBINATION Authors: Bhagdev K* And Tank C
ABSTRACT
Peptic ulcer has a major threat to the world’s population over the past two decades with
high morbidity and mortality. Development of many antacids has helped to treat the disease. A
fixed dose of combination of Ranitidine Hydrochloride and Domperidone is given to treat the
peptic ulcer. A simple, selective and reproducible reverse phase high performance liquid
chromatography (RP-HPLC) method has been developed and validated for estimation of
Ranitidine Hydrochloride and Domperidone in synthetic mixture. Chromatographic separation
was performed on a HPLC apparatus Cecil CE 4300 having pump CE4100 and reversed-phase
Thermo hypersil C18 100Å column (250 mm ×4.6 mm × 5 ?m) using an isocratic elution of
mobile phase consisting of Aetonitrile: Orthophosphoric acid (pH 3.5 adjusted by 3%
triethylamine) (50:50 v/v) at a flow rate of 0.5 ml/min. Wavelength for HPLC method of both
the drugs was selected by performing UV. Common absorbance wavelength for Ranitidine
Hydrochloride and Domperidone was 296nm. The RP-HPLC method give good resolution for
both the drugs. The method was validated for accuracy, precision, linearity, limit of detection,
limit of quantitation and ruggedness. The system suitability parameter, such as theoretical plate,
asymmetry, and resolution between standard five replicate were well within the limits.
Keywords: Domperidone, Ranitidine Hydrochloride, RP-HPLC method, Validation Parameters Publication date: 15/06/2023 https://ijbpas.com/pdf/2023/June/MS_IJBPAS_2023_JUNE_SPCL_1049.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2023/12.6.1049